Distinct blood endothelial cells shape spatial niches in angioimmunoblastic T-cell lymphoma

Y Yuki Shimizu M Manabu Fujisawa (2Institute of Medicine, University of Tsukuba, Department of Hematology, Tsukuba, Japan) Y Yoshiaki Abe (2Institute of Medicine, University of Tsukuba, Department of Hematology, Tsukuba, Japan) K Kenichi Makishima (4University of Tsukuba Hospital, Department of Hematology, Tsukuba, Japan) S Sakurako Suma (4University of Tsukuba Hospital, Department of Hematology, Tsukuba, Japan) Y Yasuhito Suehara (2Institute of Medicine, University of Tsukuba, Department of Hematology, Tsukuba, Japan) K Keiichiro Hattori (2Institute of Medicine, University of Tsukuba, Department of Hematology, Tsukuba, Japan) T Tatsuhiro Sakamoto (2Institute of Medicine, University of Tsukuba, Department of Hematology, Tsukuba, Japan) K Kyohei Sano (5Graduate School of Medicine, The University of Tokyo, Department of Preventive Medicine, Tokyo, Japan) A Ayumu Tsubosaka (5Graduate School of Medicine, The University of Tokyo, Department of Preventive Medicine, Tokyo, Japan) M Miwako Kakiuchi D Daisuke Kaji (1Toranomon Hospital, Tokyo, Japan, Department of Hematology, Tokyo, Japan) A Ayako Suzuki K Kensuke Usuki (8Mizonokuchi Hospital, Teikyo University School of Medicine, Forth Department of Internal Medicine, Kawasaki, Japan) K Kosei Matsue (25Kameda Medical Center, Chiba, Japan) Y Yasunori Ota (10The Institute of Medical Science, The University of Tokyo, Department of Pathology, Tokyo, Japan) S Shigeru Chiba S Shumpei Ishikawa Y Yutaka Suzuki C Christian Steidl (5Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, Canada) M Mamiko Sakata-Yanagimoto (Department of Hematology (M.S.-Y., S.C.), University of Tsukuba, Japan.)

Abstract

Abstract Background Angioimmunoblastic T cell lymphoma (AITL) is a subtype of peripheral T-cell lymphoma with a poor prognosis. Pathologically, AITL is characterized by the proliferation of diverse stromal cells (SCs), including blood endothelial cells (BECs) and follicular dendritic cells (FDCs). However, the tumor histology exhibits considerable heterogeneity, both between and within patients. It is hypothesized that these SCs form a supportive tumor microenvironment, and their histological heterogeneity may influence the clinical course. We previously reported that single-cell RNA sequencing (scRNA-seq) of SCs in lymph nodes (LNs) identified 30 distinct SC subclusters (Nat Cell Biol, 2022). However, the specific SC subclusters involved in AITL tumorigenesis remain undefined. Aims We aimed to characterize the SC heterogeneity in AITL microenvironments by employing scRNA-seq and spatial multi-omics at single-cell resolution. Methods Non-hematopoietic cells were isolated from 10 AITL and 5 normal LNs using magnetic- and fluorescence-activated cell sorting, followed by scRNA-seq. Based on the scRNA-seq data of SCs and immune cells, we designed a 289-gene panel for spatial transcriptomics (ST) using Xenium in situ, and a 50-protein panel for spatial proteomics (SP) using PhenoCycler fusion targeting immune cell and SC subclusters. These assays were applied to 27 formalin-fixed paraffin-embedded AITL samples. Whole exome sequencing (WES) was successfully performed on 26 of the 27 samples. We analyzed a bulk RNA-seq dataset of 97 AITL to validate the prognostic potential of gene expression patterns. Results First, we analyzed scRNA-seq data from 49,363 stroma cells and identified 30 SC subclusters consistent with our prior findings. Notably, transitional BECs between capillary BECs and activated high endothelial venules (C-aHEVs) expressed markers of both capillary BECs and HEVs, and were further subdivided into C-aHEV1 and C-aHEV2. Both tip cells, which contribute to angiogenesis, and C-aHEV2 were increased in AITL samples. Differentially expressed genes analysis revealed that both C-aHEV1 and C-aHEV2 highly expressed ACKR1. Notably, C-aHEV1 exhibited high expression of chemokines such as CXCL10 and CXCL12, whereas C-aHEV2 expressed genes encoding extracellular matrix proteins. Interaction analysis revealed that the CCL5-ACKR1 axis, which is known as a regulator of leukocyte migration, was activated between CD8-positive T cells and C-aHEVs. Furthermore, the COL15A1-integrin and SPARC-ENG axis, both of which have been reported to promote angiogenesis, were specifically enriched between C-aHEV2 and other HEVs. ST analysis of 2,020,192 cells identified 10 BEC subclusters, 5 non-endothelial SC subclusters, and 12 immune/tumor cell subclusters. Spatial proximity measurement revealed that C-aHEV1 was the BEC subcluster most closely associated with tumor cells. Spatial niche analysis revealed that C-aHEV1, together with FDCs, formed a distinct tumor-associated niche (CFT niche). On the other hand, C-aHEV2 was localized farther from the tumor than C-aHEV1, and formed a niche in conjunction with other HEV subclusters (HEV niche). The CFT niche-dense area and the HEV niche-dense area were often in close proximity, and the densities of CXCR4, encoding areceptor for CXCL12, and LAG3 and CXCR6, serving as T-cell exhaustion markers, were high in the CFT niche. SP analysis detected 6,172,072 cells and identified SCs containing 5 BEC components (artery, capillary, C-aHEV, HEV, and vein), tumor cells, and immune cell subtypes. C-aHEVs tended to be located closer to tumor cells than other BECs and formed a unified vascular niche in conjunction with HEV. WES analysis revealed the recurrent G17V RHOA mutations in 19 samples. Notably, samples harboring G17V RHOA mutations exhibited significantly higher densities of C-aHEV2 cells. Bulk RNA-seq analysis revealed that patients with high expression of C-aHEVs and other HEV-related signature exhibited poorer survival outcomes. Summary/ Conclusion By integrating scRNA-seq and spatial data, we identified C-aHEVs as key components in shaping the AITL microenvironment through the recruitment of immune cells. As the gene expression level, C-aHEVs can be subdivided into C-aHEV1 and C-aHEV2, which exhibited distinct properties. Further investigation is needed to validate the mechanisms by which these BEC clusters interact with tumor cells and contribute to tumorigenesis.

Article Details

Journal Blood
Volume / Issue Vol. 146, Issue Supplement 1
Published November 03, 2025
Pages 462-462
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (21)

Y

Yuki Shimizu

M

Manabu Fujisawa

2Institute of Medicine, University of Tsukuba, Department of Hematology, Tsukuba, Japan

Y

Yoshiaki Abe

2Institute of Medicine, University of Tsukuba, Department of Hematology, Tsukuba, Japan

K

Kenichi Makishima

4University of Tsukuba Hospital, Department of Hematology, Tsukuba, Japan

S

Sakurako Suma

4University of Tsukuba Hospital, Department of Hematology, Tsukuba, Japan

Y

Yasuhito Suehara

2Institute of Medicine, University of Tsukuba, Department of Hematology, Tsukuba, Japan

K

Keiichiro Hattori

2Institute of Medicine, University of Tsukuba, Department of Hematology, Tsukuba, Japan

T

Tatsuhiro Sakamoto

2Institute of Medicine, University of Tsukuba, Department of Hematology, Tsukuba, Japan

K

Kyohei Sano

5Graduate School of Medicine, The University of Tokyo, Department of Preventive Medicine, Tokyo, Japan

A

Ayumu Tsubosaka

5Graduate School of Medicine, The University of Tokyo, Department of Preventive Medicine, Tokyo, Japan

M

Miwako Kakiuchi

D

Daisuke Kaji

1Toranomon Hospital, Tokyo, Japan, Department of Hematology, Tokyo, Japan

A

Ayako Suzuki

K

Kensuke Usuki

8Mizonokuchi Hospital, Teikyo University School of Medicine, Forth Department of Internal Medicine, Kawasaki, Japan

K

Kosei Matsue

25Kameda Medical Center, Chiba, Japan

Y

Yasunori Ota

10The Institute of Medical Science, The University of Tokyo, Department of Pathology, Tokyo, Japan

S

Shigeru Chiba

S

Shumpei Ishikawa

Y

Yutaka Suzuki

C

Christian Steidl

5Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, Canada

M

Mamiko Sakata-Yanagimoto

Department of Hematology (M.S.-Y., S.C.), University of Tsukuba, Japan.